Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB

Overview of attention for article published in Frontiers in immunology, March 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 16 news outlets
twitter: 2 X users

patent: 5 patents

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 84 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF

Application WO-2023239940-A1

World Intellectual Property Organisation (WIPO)

NOVEL COMBINATIONS OF ANTIBODIES AND USES THEREOF

Application WO-2022189508-A1

World Intellectual Property Organisation (WIPO)

ARTICLES OF MANUFACTURE COMPRISING ANTI PD-L1 ANTIBODIES AND THEIR USE IN THERAPY

Application WO-2021152590-A1

World Intellectual Property Organisation (WIPO)

ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS

Application WO-2021009358-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.